Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
937245-42-6COc1cc2c(cc1OCCCF)CCN1C[C@@H](CC(C)C)[C@H](O)C[C@H]21GNKGXQHHUUEYQV-BHIYHBOVSA-N937245-42-6CHEMBL579217CHEBI:230930BeschreibungFlorbenazine (AV-133) is a fluorinated VMAT-2 ligand for PET. It is designed to measure dopaminergic degeneration by in vivo assessment of striat VMAT2 density in patients with Parkinson’s disease (PD). Besides differentiating PD from essential tremor and drug-induced parkinsonism, PET imaging of VMAT2 may help in differentiating Dementia with Lewy Bodies (DLB) from Alzheimer’s disease. AV-45 (florbetapir, AmyvidTM) is the first PET ligand to receive US FDA approval to assess neuritic plaque amyloid[1-2].
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…